Cell therapy for the creation of cartilage and related clinical trials

Gene and Cell Therapy: Therapeutic Mechanisms and Strategies, Fourth Edition

Volumn , Issue , 2015, Pages 1123-1135

  Karnes, Jonathan ^a   Zhang, Ying ^a   Pei, Ming ^b  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84929518450     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/b18002     Document Type: Chapter

References (173)

1. Urban, J.P., The chondrocyte: A cell under pressure. Br J Rheumatol, 1994. 33(10): 901-908.
2. Webb, S.T. and S. Ghosh, Intra-articular bupivacaine: Potentially chondrotoxic? Br J Anaesth, 2009. 102(4): 439-441.
3. Archer, C.W. et al., Enhancing tissue integration in cartilage repair procedures. JAnat, 2006. 209(4): 481-493.
4. Lu, Y. et al., Minced cartilage without cell culture serves as an effective intraoperative cell source for cartilage repair. J Orthop Res, 2006. 24(6): 1261-1270.
5. D’Lima, D.D. et al., Impact of mechanical trauma on matrix and cells. Clin Orthop Relat Res, 2001(391 Suppl): S90-S99.
6. Tew, S.R. et al., The reactions of articular cartilage to experimental wounding: Role of apoptosis. Arthritis Rheum, 2000. 43(1): 215-225.
7. Buckwalter, J. and H. Mankin, Articular cartilage. Part 1: Tissue design and chondrocyte-matrix interactions-Instruc-tional Course Lecture-The American Academy of Orthopaedic Surgeons. J Bone Joint Surg Am, 1997. 79A(4): 600-611.
8. Solomon, D.J. et al., Glenohumeral chondrolysis after arthroscopy: A systematic review of potential contributors and causal pathways. Arthroscopy, 2009. 25(11): 1329-1342.
9. Mithoefer, K. et al., The microfracture technique for the treatment of articular cartilage lesions in the knee. A prospective cohort study. J Bone Joint Surg Am, 2005. 87(9): 1911-1920.
10. Buckwalter, J. and H. Mankin, Articular cartilage. Part 2: Degeneration and osteoarthrosis, repair, regeneration, and transplantation-instructional Course Lecture-The American Academy of Orthopaedic Surgeons. J Bone Joint Surg Am, 1997. 79A(4): 612-632.
11. Mithoefer, K. et al., Clinical efficacy of the microfracture technique for articular cartilage repair in the knee. Am J Sports Med, 2009. 37: 2053-2063.
12. Harris, J. et al., Treatment of chondral defects in the athlete’s knee. Arthroscopy, 2010. 26(6): 841-852.
13. Nehrer, S., M. Spector, and T. Minas, Histologic analysis of tissue after failed cartilage repair procedures. Clin Orthod Res, 1999. 365: 149-162.
14. LaPrade, R. et al., Histologic and immunohistochemical characteristics of failed articular cartilage resurfacing procedures for osteochondritis of the knee. Am J Sports Med, 2008. 36(2): 360-368.
15. Steadman, J. et al., Outcomes of microfracture for traumatic chondral defects of the knee: Average 11-year follow-up. Arthroscopy, 2003. 19(5): 477-484.
16. Benthien, J.P., M. Schwaninger, and P. Behrens, We do not have evidence based methods for the treatment of cartilage defects in the knee. Knee Surg Sports Traumatol Arthrose, 2011. 19(4): 543-552.
17. Hambly, K. and K. Griva, IKDC or KOOS? Which measures symptoms and disabilities most important to postoperative articular cartilage repair patients? Am J Sports Med, 2008. 36(9): 1695-1704.
18. Higgins, L.D. et al., Reliability and validity of the International Knee Documentation Committee (IKDC) Subjective Knee Form. Joint Bone Spine, 2007. 74(6): 594-599.
19. Bekkers, J.E. et al., Validation of the Knee Injury and Osteoarthritis Outcome Score (KOOS) for the treatment of focal cartilage lesions. Osteoarthritis Cartilage, 2009. 17(11): 1434-1439.
20. Engelhart, L. et al., Validation of the knee injury and osteoarthritis outcome score subscales for patients with articular cartilage lesions of the knee. Am J Sports Med, 2012. 40(10): 2264-2272.
21. Irrgang, J.J. et al., Development and validation of the international knee documentation committee subjective knee form. Am J Sports Med, 2001. 29(5): 600-613.
22. Jakobsen, R.B., L. Engebretsen, and J.R. Slauterbeck, An analysis of the quality of cartilage repair studies. J Bone Joint Surg Am, 2005. 87(10): 2232-2239.
23. Shelbourne, K.D., S. Jari, and T. Gray, Outcome of untreated traumatic articular cartilage defects of the knee: A natural history study. J Bone Joint Surg Am, 2003. 85-A(Suppl 2): 8-16.
24. Widuchowski, W. et al., Untreated asymptomatic deep cartilage lesions associated with anterior cruciate ligament injury: Results at 10- and 15-year follow-up. Am J Sports Med, 2009. 37(4): 688-692.
25. Salzmann, G. et al., Cartilage repair approach and treatment characteristics across the knee joint: A European survey. Arch Orthop Trauma Surg, 2011. 131(3): 283-291.
26. Depalma, A.A. and K.I. Gruson, Management of cartilage defects in the shoulder. Curr Rev Musculoskelet Med, 2012. 5(3): 254-262.
27. Oldershaw, R.A., Cell sources for the regeneration of articular cartilage: The past, the horizon and the future. Int J Exp Pathol, 2012. 93(6): 389-400.
28. Brittberg, M. et al., Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med, 1994. 331(14): 889-895.
29. Mangione, C.M. et al., Health-related quality of life after elective surgery: Measurement of longitudinal changes. J Gen Intern Med, 1997. 12(11): 686-697.
30. Bhosale, A. et al., Midterm to long-term longitudinal outcome of autologous chondrocyte implantation in the knee joint: A multilevel analysis. Am J Sports Med, 2009. 37: 131S-138S.
31. Moradi, B. et al., First-generation autologous chondrocyte implantation in patients with cartilage defects of the knee: 7 to 14 years’ clinical and magnetic resonance imaging follow-up evaluation. Arthroscopy, 2012. 28(12): 1851-1861.
32. Robertson, W.B. et al., MRI and clinical evaluation of collagen-covered autologous chondrocyte implantation (CACI) at two years. Knee, 2007. 14(2): 117-127.
33. Steinhagen, J. et al., Treatment of osteochondritis dissecans of the femoral condyle with autologous bone grafts and matrix-supported autologous chondrocytes. Int Orthop, 2010. 34(6): 819-825.
34. Ochs, B.G. et al., Remodeling of articular cartilage and subchondral bone after bone grafting and matrix-associated autologous chondrocyte implantation for osteochondritis dissecans of the knee. Am J Sports Med, 2011. 39(4): 764-773.
35. Della Villa, S. et al., Does intensive rehabilitation permit early return to sport without compromising the clinical outcome after arthroscopic autologous chondrocyte implantation in highly competitive athletes? Am J Sports Med, 2010. 38(1): 68-77.
36. Zak, L. et al., Ability to return to sports 5 years after matrix-associated autologous chondrocyte transplantation in an average population of active patients. Am J Sports Med, 2012. 40(12): 2815-2821.
37. Ebert, J.R. et al., Clinical and magnetic resonance imaging-based outcomes to 5 years after matrix-induced autologous chondrocyte implantation to address articular cartilage defects in the knee. Am J Sports Med, 2011. 39(4): 753-763.
38. Henderson, I. et al., Autologous chondrocyte implantation for treatment of focal chondral defects of the knee—A clinical, arthroscopic, MRI and histologic evaluation at 2 years. Knee, 2005. 12(3): 209-216.
39. Selmi, T.A. et al., Autologous chondrocyte implantation in a novel alginate-agarose hydrogel: Outcome at two years. J Bone Joint Surg Br, 2008. 90(5): 597-604.
40. Pietschmann, M.F. et al., The incidence and clinical relevance of graft hypertrophy after matrix-based autologous chondrocyte implantation. Am J Sports Med, 2012. 40(1): 68-74.
41. Schneider, U. et al., A prospective multicenter study on the outcome of type I collagen hydrogel-based autologous chondrocyte implantation (CaReS) for the repair of articular cartilage defects in the knee. Am J Sports Med, 2011. 39(12): 2558-2565.
42. Marcacci, M. et al., Arthroscopic second generation autologous chondrocyte implantation. Knee Surg Sports Traumatol Arthrose, 2007. 15(5): 610-619.
43. Marlovits, S. et al., Clinical and radiological outcomes 5 years after matrix-induced autologous chondrocyte implantation in patients with symptomatic, traumatic chondral defects. Am J Sports Med, 2012. 40(10): 2273-2280.
44. Kreuz, P.C. et al., Treatment of focal degenerative cartilage defects with polymer-based autologous chondrocyte grafts: Four-year clinical results. Arthritis Res Ther, 2009. 11(2): R33.
45. Kon, E. et al., Articular cartilage treatment in high-level male soccer players: A prospective comparative study of arthroscopic second-generation autologous chondrocyte implantation versus microfracture. Am J Sports Med, 2011. 39(12): 2549-2557.
46. Filardo, G. et al., Arthroscopic second-generation autologous chondrocyte implantation: A prospective 7-year follow-up study. Am J Sports Med, 2011. 39(10): 2153-2160.
47. Kon, E. et al., Second-generation autologous chondrocyte transplantation: MRI findings and clinical correlations at a minimum 5-year follow-up. Eur J Radiol, 2011. 79(3): 382-388.
48. Pelissier, A. et al., Satisfactory long-term MRI after autologous chondrocyte implantation at the knee. Knee Surg Sports Traumatol Arthrose, 2013. doi. 10.1007/s00167-013-2428-9.
49. Ferruzzi, A. et al., Autologous chondrocyte implantation in the knee joint: Open compared with arthroscopic technique. Comparison at a minimum follow-up of five years. J Bone Joint Surg Am, 2008. 90(4): 90-101.
50. Beris, A.E. et al., Treatment of full-thickness chondral defects of the knee with autologous chondrocyte implantation: A functional evaluation with long-term follow-up. Am J Sports Med, 2012. 40(3): 562-567.
51. Vasiliadis, H.S. et al., Autologous chondrocyte implantation in cartilage lesions of the knee. Am J Sports Med, 2010. 38(5): 943-949.
52. Marlovits, S. et al., Magnetic resonance observation of cartilage repair tissue (MOCART) for the evaluation of autologous chondrocyte transplantation: Determination of interobserver variability and correlation to clinical outcome after 2 years. Eur J Radiol, 2006. 57(1): 16-23.
53. Pietschmann, M.F. et al., Cell quality affects clinical outcome after MACI procedure for cartilage injury of the knee. Knee Surg Sports Traumatol Arthrose, 2009. 17(11): 1305-1311.
54. Lohmander, L.S. et al., The long-term consequence of anterior cruciate ligament and meniscus injuries: Osteoarthritis. Am J Sports Med, 2007. 35(10): 1756-1769.
55. Visna, P. et al., Treatment of deep cartilage defects of the knee using autologous chondrograft transplantation and by abrasive techniques—A randomized controlled study. Acta Chir Belg, 2004. 104(6): 709-714.
56. Crawford, D.C., T.M. Deberardino, and R.J. Williams, NeoCart, an autologous cartilage tissue implant, compared with microfracture for treatment of distal femoral cartilage lesions: An FDA phase-II prospective, randomized clinical trial after two years. J Bone Joint Surg Am, 2012. 94(11): 979-989.
57. Saris, D.B. et al. Treatment of symptomatic cartilage defects of the knee: Characterized chondrocyte implantation results in better clinical outcome at 36 months in a randomized trial compared to microfracture. Am J Sports Med, 2009. 37(Suppl 1), 10s-19s.
58. Saris, D.B. et al. Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture. Am J Sports Med, 2008. 36(2): 235-246.
59. Vanlauwe, J. et al., Five-year outcome of characterized chondrocyte implantation versus microfracture for symptomatic cartilage defects of the knee: Early treatment matters. Am J Sports Med, 2011. 39(12): 2566-2574.
60. Kon, E. et al., Arthroscopic second-generation autologous chondrocyte implantation compared with microfracture for chondral lesions of the knee: Prospective nonrandomized study at 5 years. Am J Sports Med, 2009. 37(1): 33-41.
61. Petri, M. et al., CaReS((R)) (MACT) versus microfracture in treating symptomatic patellofemoral cartilage defects: A retrospective matched-pair analysis. J Orthop Sci, 2013. 18(1): 38-44.
62. Kusano, T. et al., Treatment of isolated chondral and osteochondral defects in the knee by autologous matrix-induced chondrogenesis (AMIC). Knee Surg Sports Traumatol Arthrosc, 2012. 20(10): 2109-2115.
63. Panagopoulos, A., L. van Niekerk, and I. Triantafillopoulos, Autologous chondrocyte implantation for knee cartilage injuries: Moderate functional outcome and performance in patients with high-impact activities. Orthopedics, 2012. 35(1): e6-e14.
64. Zeifang, F. et al., Autologous chondrocyte implantation using the original periosteum-cover technique versus matrix-associated autologous chondrocyte implantation: A randomized clinical trial. Am J Sports Med, 2010. 38(5): 924-933.
65. Niemeyer, P. et al., Autologous chondrocyte implantation for the treatment of retropatellar cartilage defects: Clinical results referred to defect localisation. Arch Orthop Trauma Surg, 2008. 128(11): 1223-1231.
66. Flohé, S. et al., Comparison of two different matrix-based autologous chondrocyte transplantation systems: 1 year follow-up results. Eur J Trauma Emerg Surg, 2011. 37(4): 397-403.
67. Lutianov, M. et al., A mathematical model of cartilage regeneration after cell therapy. J Theor Biol, 2011. 289: 136-150.
68. Nehrer, S. et al., Treatment of full-thickness chondral defects with hyalograft C in the knee: A prospective clinical case series with 2 to 7 years’ follow-up. Am J Sports Med, 2009. 37(Suppl 1): 81S-87S.
69. Nehrer, S. et al., Three-year clinical outcome after chondrocyte transplantation using a hyaluronan matrix for cartilage repair. Eur J Radiol, 2006. 57(1): 3-8.
70. Niemeyer, P. et al., Influence of cell quality on clinical outcome after autologous chondrocyte implantation. Am J Sports Med, 2012. 40(3): 556-561.
71. Bauer, S. et al., Knee joint preservation with combined neutralising high tibial osteotomy (HTO) and Matrix-induced Autologous Chondrocyte Implantation (MACI) in younger patients with medial knee osteoarthritis: A case series with prospective clinical and MRI follow-up over 5 years. Knee, 2012. 19(4): 431-439.
72. Wondrasch, B. et al., Effect of accelerated weightbearing after matrix-associated autologous chondrocyte implantation on the femoral condyle on radiographic and clinical outcome after 2 years: A prospective, randomized controlled pilot study. Am J Sports Med, 2009. 37(Suppl 1): 88S-96S.
73. Ebert, J.R. et al., A randomized trial comparing accelerated and traditional approaches to postoperative weightbearing rehabilitation after matrix-induced autologous chondrocyte implantation: Findings at 5 years. Am J Sports Med, 2012. 40(7): 1527-1537.
74. Vascellari, A. et al., Implantation of matrix-induced autologous chondrocyte (MACI((R))) grafts using carbon dioxide insufflation arthroscopy. Knee Surg Sports Traumatol Arthrosc, 2014. 22(1): 219-225.
75. Filardo, G. et al., Matrix-assisted autologous chondrocyte transplantation for cartilage regeneration in osteoarthritic knees: Results and failures at midterm follow-up. Am J Sports Med, 2013. 41(1): 95-100.
76. Pascual-Garrido, C. et al., Recommendations and treatment outcomes for patellofemoral articular cartilage defects with autologous chondrocyte implantation: Prospective evaluation at average 4-year follow-up. Am J Sports Med, 2009. 37(Suppl 1): 33S-41S.
77. Pestka, J.M. et al., Clinical outcome of autologous chondrocyte implantation for failed microfracture treatment of fullthickness cartilage defects of the knee joint. Am J Sports Med, 2012. 40(2): 325-331.
78. Zaslav, K. et al., A prospective study of autologous chondrocyte implantation in patients with failed prior treatment for articular cartilage defect of the knee: Results of the Study of the Treatment of Articular Repair (STAR) clinical trial. Am J Sports Med, 2009. 37(1): 42-55.
79. Niemeyer, P. et al., Chondrocyte-seeded type I/III collagen membrane for autologous chondrocyte transplantation: Prospective 2-year results in patients with cartilage defects of the knee joint. Arthroscopy, 2010. 26(8): 1074-1082.
80. Niemeyer, P. et al., Autologous chondrocyte implantation for treatment of focal cartilage defects in patients age 40 years and older. Am J Sports Med, 2010. 38(12): 2410-2416.
81. Nejadnik, H. et al., Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: An observational cohort study. Am J Sports Med, 2010. 38(6): 1110-1116.
82. Paradowski, P.T. et al., The effect of patient characteristics on variability in pain and function over two years in early knee osteoarthritis. Health Qual Life Outcomes, 2005. 3: 59.
83. Kreuz, P.C. et al., Is gender influencing the biomechanical results after autologous chondrocyte implantation? Knee Surg Sports Traumatol Arthrosc, 2014. 22(1): 72-79.
84. Peterson, L. et al., Autologous chondrocyte implantation: A long-term follow-up. Am J Sports Med, 2010. 38(6): 1117-1124.
85. Steinhagen, J. et al., Treatment of osteochondritis dissecans of the femoral condyle with autologous bone grafts and matrix-supported autologous chondrocytes. Int Orthop, 2010. 34(6): 819-825.
86. Marcacci, M. et al., Articular cartilage engineering with Hyalograft C: 3-year clinical results. Clin Orthop Relat Res, 2005(435): 96-105.
87. Hayflick, L., The limited in vitro lifetime of human diploid cell strains. Exp Cell Res, 1965. 37: 614-636.
88. Benya, P.D. and J.D. Shaffer, Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell, 1982. 30(1): 215-224.
89. von der Mark, K. et al., Relationship between cell shape and type of collagen synthesised as chondrocytes lose their cartilage phenotype in culture. Nature, 1977. 267(5611): 531-532.
90. Barbero, A. et al., Age related changes in human articular chondrocyte yield, proliferation and post-expansion chondrogenic capacity. Osteoarthritis Cartilage, 2004. 12(6): 476-484.
91. Matricali, G.A., G.P. Dereymaeker, and F.P. Luyten, Donor site morbidity after articular cartilage repair procedures: A review. Acta Orthop Belg, 2010. 76(5): 669-674.
92. Keller, G., Embryonic stem cell differentiation: Emergence of a new era in biology and medicine. Genes Dev, 2005. 19(10): 1129-1155.
93. Daley, G.Q., M.A. Goodell, and E.Y. Snyder, Realistic prospects for stem cell therapeutics. Hematology Am Soc Hematol Educ Program, 2003: 398-418.
94. O’Sullivan, J. et al., Mesenchymal chondroprogenitor cell origin and therapeutic potential. Stem Cell Res Ther, 2011. 2(1): 8.
95. Morrison, S.J., N.M. Shah, and D.J. Anderson, Regulatory mechanisms in stem cell biology. Cell, 1997. 88(3): 287-298.
96. Weissman, I.L., Stem cells: Units of development, units of regeneration, and units in evolution. Cell, 2000. 100(1): 157-168.
97. Behr, B. et al., Stem cells. Plast Reconstr Surg, 2010. 126(4): 1163-1171.
98. Takahashi, K. and S. Yamanaka, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 2006. 126(4): 663-676.
99. Takahashi, K. et al., Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 2007. 131(5): 861-872.
100. Kim, M.J. et al., Generation of human induced pluripotent stem cells from osteoarthritis patient-derived synovial cells. Arthritis Rheum, 2011. 63(10): 3010-3021.
101. Wei, Y. et al., Chondrogenic differentiation of induced pluripotent stem cells from osteoarthritic chondrocytes in alginate matrix. Eur Cell Mater, 2012. 23: 1-12.
102. Diekman, B.O. et al., Cartilage tissue engineering using differentiated and purified induced pluripotent stem cells. Proc Natl Acad Sci USA, 2012. 109(47): 19172-19177.
103. Wakitani, S. et al., Embryonic stem cells injected into the mouse knee joint form teratomas and subsequently destroy the joint. Rheumatology (Oxford), 2003. 42(1): 162-165.
104. Wu, S.M. and K. Hochedlinger, Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol, 2011. 13(5): 497-505.
105. Bushman, F.D., Retroviral integration and human gene therapy. J Clin Invest, 2007. 117(8): 2083-2086.
106. Bosch, P. et al., Osteoprogenitor cells within skeletal muscle. J Orthop Res, 2000. 18(6): 933-944.
107. Okita, K., T. Ichisaka, and S. Yamanaka, Generation of germ-line-competent induced pluripotent stem cells. Nature, 2007. 448(7151): 313-317.
108. Mikkelsen, T.S. et al., Dissecting direct reprogramming through integrative genomic analysis. Nature, 2008. 454(7200): 49-55.
109. Solchaga, L.A. et al., Fibroblast growth factor-2 enhances proliferation and delays loss of chondrogenic potential in human adult bone-marrow-derived mesenchymal stem cells. Tissue Eng Part A, 2010. 16(3): 1009-1019.
110. Bonyadi, M. et al., Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice. Proc Natl Acad Sci USA, 2003. 100(10): 5840-5845.
111. Chen, F.H., K.T. Rousche, and R.S. Tuan, Technology Insight: Adult stem cells in cartilage regeneration and tissue engineering. Nat Clin Pract Rheumatol, 2006. 2(7): 373-382.
112. Grande, D.A. et al., Repair of articular cartilage defects using mesenchymal stem cells. Tissue Eng, 1995. 1(4): 345-353.
113. Koga, H. et al., Mesenchymal stem cell-based therapy for cartilage repair: A review. Knee Surg Sports Traumatol Arthrosc, 2009. 17(11): 1289-1297.
114. Huade Li et al., Rat cartilage repair using nanophase PLGA/HA composite and mesenchymal stem cells. JBioact Compat Pol, 2009. 24(1): 83-99.
115. Centeno, C.J. et al., Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells. Pain Phys, 2008. 11(3): 343-353.
116. Centeno, C.J. et al., Regeneration of meniscus cartilage in a knee treated with percutaneously implanted autologous mesenchymal stem cells. Med Hypotheses, 2008. 71(6): 900-908.
117. Steadman, J.R., W.G. Rodkey, and J.J. Rodrigo, Microfracture: Surgical technique and rehabilitation to treat chondral defects. Clin Orthop Relat Res, 2001(391 Suppl): S362-S369.
118. Friedenstein, A.J., S. Piatetzky, II, and K.V. Petrakova, Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol, 1966. 16(3): 381-390.
119. da Silva Meirelles, L., P.C. Chagastelles, and N.B. Nardi, Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci, 2006. 119(Part 11): 2204-2213.
120. Zuk, P.A. et al., Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng, 2001. 7(2): 211-228.
121. Nakahara, H., V.M. Goldberg, and A.I. Caplan, Culture-expanded human periosteal-derived cells exhibit osteochondral potential in vivo. J Orthop Res, 1991. 9(4): 465-476.
122. De Bari, C., F. Dell’Accio, and F.P. Luyten, Human periosteum-derived cells maintain phenotypic stability and chondro-genic potential throughout expansion regardless of donor age. Arthritis Rheum, 2001. 44(1): 85-95.
123. De Bari, C. et al., Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum, 2001. 44(8): 1928-1942.
124. Noth, U. et al., Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells. J Orthop Res, 2002. 20(5): 1060-1069.
125. Osyczka, A.M. et al., Different osteochondral potential of clonal cell lines derived from adult human trabecular bone. Ann N YAcad Sci, 2002. 961: 73-77.
126. Young, H.E. et al., Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec, 2001. 264(1): 51-62.
127. Brighton, C.T. et al., The pericyte as a possible osteoblast progenitor cell. Clin Orthop Relat Res, 1992(275): 287-299.
128. Zvaifler, N.J. et al., Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res, 2000. 2(6): 477-488.
129. Miura, M. et al., SHED: Stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci USA, 2003. 100(10): 5807-5812.
130. Friedenstein, A.J., J.F. Gorskaja, and N.N. Kulagina, Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol, 1976. 4(5): 267-274.
131. Glennie, S. et al., Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood, 2005. 105(7): 2821-2827.
132. Krebsbach, P.H. et al., Bone marrow stromal cells: Characterization and clinical application. Crit Rev Oral Biol Med, 1999. 10(2): 165-181.
133. Zuk, P.A. et al., Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell, 2002. 13(12): 4279-4295.
134. Nathan, S. et al., Cell-based therapy in the repair of osteochondral defects: A novel use for adipose tissue. Tissue Eng, 2003. 9(4): 733-744.
135. Im, G.I., Y.W. Shin, and K.B. Lee, Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthritis Cartilage, 2005. 13(10): 845-853.
136. Huang, J.I. et al., Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: A patient-matched comparison. J Orthop Res, 2005. 23(6): 1383-1389.
137. Liu, T.M. et al., Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells, 2007. 25(3): 750-760.
138. Rider, D.A. et al., Autocrine fibroblast growth factor 2 increases the multipotentiality of human adipose-derived mesenchymal stem cells. Stem Cells, 2008. 26(6): 1598-1608.
139. Winter, A. et al., Cartilage-like gene expression in differentiated human stem cell spheroids: A comparison of bone marrow-derived and adipose tissue-derived stromal cells. Arthritis Rheum, 2003. 48(2): 418-429.
140. Murphy, J.M. et al., Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum, 2003. 48(12): 3464-3474.
141. Lee, K.B. et al., Injectable mesenchymal stem cell therapy for large cartilage defects—A porcine model. Stem Cells, 2007. 25(11): 2964-2971.
142. Wakitani, S. et al., Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am, 1994. 76(4): 579-592.
143. Wakitani, S. et al., Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: Two case reports. Cell Transplant, 2004. 13(5): 595-600.
144. Sakaguchi, Y. et al., Comparison of human stem cells derived from various mesenchymal tissues: Superiority of synovium as a cell source. Arthritis Rheum, 2005. 52(8): 2521-2529.
145. Pei, M., F. He, and G. Vunjak-Novakovic, Synovium-derived stem cell-based chondrogenesis. Differentiation, 2008. 76(10): 1044-1056.
146. Yoshimura, H. et al., Comparison of rat mesenchymal stem cells derived from bone marrow, synovium, periosteum, adipose tissue, and muscle. Cell Tissue Res, 2007. 327(3): 449-462.
147. Koga, H. et al., Comparison of mesenchymal tissues-derived stem cells for in vivo chondrogenesis: Suitable conditions for cell therapy of cartilage defects in rabbit. Cell Tissue Res, 2008. 333(2): 207-215.
148. Pei M, Can synovium-derived stem cells deposit matrix with chondrogenic lineage-specific determinants? J Tissue Sci Eng, 2012. 3: 3.
149. Mochizuki, T. et al., Higher chondrogenic potential of fibrous synovium- and adipose synovium-derived cells compared with subcutaneous fat-derived cells: Distinguishing properties of mesenchymal stem cells in humans. Arthritis Rheum, 2006. 54(3): 843-853.
150. Pei, M. et al., Repair of full-thickness femoral condyle cartilage defects using allogeneic synovial cell-engineered tissue constructs. Osteoarthritis Cartilage, 2009. 17(6): 714-722.
151. Suzuki, S. et al., Properties and usefulness of aggregates of synovial mesenchymal stem cells as a source for cartilage regeneration. Arthritis Res Ther, 2012. 14(3): R136.
152. Lee, J.C. et al., Synovial membrane-derived mesenchymal stem cells supported by platelet-rich plasma can repair osteochondral defects in a rabbit model. Arthroscopy, 2013. 29(6): 1034-1046.
153. Li, J. and M. Pei, Optimization of an in vitro three-dimensional microenvironment to reprogram synovium-derived stem cells for cartilage tissue engineering. Tissue Eng Part A, 2011. 17(5-6): 703-712.
154. Portron, S. et al., Effects of in vitro low oxygen tension preconditioning of adipose stromal cells on their in vivo chon-drogenic potential: Application in cartilage tissue repair. PLoS One, 2013. 8(4): e62368.
155. D’Ippolito, G. et al., Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci, 2004. 117(Part 14): 2971-2981.
156. Holland, T.A. et al., Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. Osteoarthritis Cartilage, 2007. 15(2): 187-197.
157. Jaklenec, A. et al., Sequential release of bioactive IGF-I and TGF-beta 1 from PLGA microsphere-based scaffolds. Biomaterials, 2008. 29(10): 1518-1525.
158. Oh, C.D. et al., Opposing role of mitogen-activated protein kinase subtypes, erk-1/2 and p38, in the regulation of chondrogenesis of mesenchymes. J Biol Chem, 2000. 275(8): 5613-5619.
159. Stanton, L.A., T.M. Underhill, and F. Beier, MAP kinases in chondrocyte differentiation. Dev Biol, 2003. 263(2): 165-175.
160. Im, G.I. and Z. Quan, The effects of Wnt inhibitors on the chondrogenesis of human mesenchymal stem cells. Tissue Eng Part A, 2010. 16(7): 2405-2413.
161. Cucchiarini, M. and H. Madry, Genetic modification of mesenchymal stem cells for cartilage repair. Biomed Mater Eng, 2010. 20(3): 135-143.
162. He, F., X. Chen, and M. Pei, Reconstruction of an in vitro tissue-specific microenvironment to rejuvenate synovium-derived stem cells for cartilage tissue engineering. Tissue Eng Part A, 2009. 15(12): 3809-3821.
163. Pei, M. et al., A review of decellularized stem cell matrix: A novel cell expansion system for cartilage tissue engineering. Eur Cell Mater, 2011. 22: 333-343; discussion 343.
164. Pei, M. et al., Antioxidation of decellularized stem cell matrix promotes human synovium-derived stem cell-based chondrogenesis. Stem Cell Dev, 2013. 22(6): 889-900.
165. Yang, Z. et al., Fabrication and repair of cartilage defects with a novel acellular cartilage matrix scaffold. Tissue Eng Part C Methods, 2010. 16(5): 865-876.
166. Davatchi, F. et al., Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients. Int J Rheum Dis, 2011. 14(2): 211-215.
167. Emadedin, M. et al., Intra-articular injection of autologous mesenchymal stem cells in six patients with knee osteoarthritis. Arch Iran Med, 2012. 15(7): 422-428.
168. Pei, M. et al., Repair of large animal partial-thickness cartilage defects through intraarticular injection of matrix-rejuvenated synovium-derived stem cells. Tissue Eng Part A, 2013. 19(9-10): 1144-1154.
169. Mizuno, K. et al., Exogenous synovial stem cells adhere to defect of meniscus and differentiate into cartilage cells. J Med Dent Sci, 2008. 55(1): 101-111.
170. Koga, H. et al., Local adherent technique for transplanting mesenchymal stem cells as a potential treatment of cartilage defect. Arthritis Res Ther, 2008. 10(4): R84.
171. Lu, H. et al., Autologous extracellular matrix scaffolds for tissue engineering. Biomaterials, 2011. 32(10): 2489-2499.
172. Noth, U., A.F. Steinert, and R.S. Tuan, Technology insight: Adult mesenchymal stem cells for osteoarthritis therapy. Nat Clin Pract Rheumatol, 2008. 4(7): 371-380.
173. Benders, K.E. et al., Extracellular matrix scaffolds for cartilage and bone regeneration. Trends Biotechnol, 2013. 31(3): 169-176.